Analysis of Immune Reactions Occurring in Normal Volunteers Upon Administration of the Topical Immunomodulator Diphenylcyclopropenone
Phase of Trial: Phase I
Latest Information Update: 04 Sep 2013
At a glance
- Drugs Diphencyprone (Primary)
- Indications Cancer
- Focus Pharmacodynamics
- 01 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Oct 2011 New trial record